The role of catecholamines in circulatory regulation on the chronic congestive heart failure. Clinical study of the urinary catecholamine excretion in the patients with chronic congestive heart failure.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001794:Blood Pressure; D009202:Cardiomyopathies / Q000150:complications; D002395:Catecholamines / Q000652:urine*; D003327:Coronary Disease / Q000150:complications; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D004837:Epinephrine / Q000652:urine; D005260:Female; D005919:Glomerular Filtration Rate; D006145:Guanethidine / Q000627:therapeutic use; D006330:Heart Defects, Congenital / Q000150:complications; D006333:Heart Failure / Q000188:drug therapy / Q000652:urine*; D006349:Heart Valve Diseases / Q000150:complications; D006801:Humans; D006852:Hydrochlorothiazide / Q000627:therapeutic use; D006973:Hypertension / Q000150:complications; D007799:Lanatosides / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009638:Norepinephrine / Q000652:urine*; D011188:Potassium / Q000097:blood; D012039:Regional Blood Flow; D012964:Sodium / Q000097:blood / Q000652:urine; D013148:Spironolactone / Q000627:therapeutic use; D014237:Trichlormethiazide / Q000627:therapeutic use
D002395:Catecholamines; D004071:Digitalis Glycosides; D004232:Diuretics; D007799:Lanatosides; D006852:Hydrochlorothiazide; D013148:Spironolactone; D012964:Sodium; D014237:Trichlormethiazide; D011188:Potassium; D009638:Norepinephrine; D004837:Epinephrine; D006145:Guanethidine